References for ALTACE.com

1. ALTACE^® PI. Monarch Pharmaceuticals. September 2005.

2. Stedman’s Dictionary (online) and Stedman’s Dictionary 25th Edition, 1990.

3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04-5230. August 2004.

4. National Center for Health Statistics. Health, United States, 2005 with Chartbook on Trends in the Health of Americans. Hyattsville, Md. 2006.

5. US Census Bureau. Statistical Abstract of the United States: 2007 (126th Edition). Washington, DC. 2005. Available at: http://www.census.gov/statab/.

6. CDC [Centers for Disease Control and Prevention]. Racial/ethnic disparities in prevalence, treatment, and control of hypertension—United States, 1999-2002. MMWR Morbid Mortal Wkly Rep 2005;54:7-9.

7. NHLBI [National Institutes of Health, National Heart, Lung, and Blood Institute]. Your Guide to Lowering Blood Pressure. NIH Publication No. 03-5232. May 2003.

8. Kaplan NM. Systemic hypertension: mechanisms and diagnosis [Chapter 37]. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, Pa: Elsevier Saunders; 2005:959-987.

9. Dosh SA. The treatment of adults with essential hypertension. J Fam Pract 2002;51:74-79.

10. Whelton PK. Epidemiology and the prevention of hypertension. J Clin Hypertens 2004;6:636-642.

11. Kannel WB. Hypertensive risk assessment: cardiovascular risk factors and hypertension. J Clin Hypertens (Greenwich) 2004;6:393-399.

12. AHRQ [Agency for Healthcare Research and Quality]. Next Steps After Your Diagnosis: Finding Information and Support. AHRQ Publication No. 05-0049. July 2005.

13. NIH [National Institutes of Health]. Your Guide to Lowering Your Blood Pressure with DASH. NIH Publication No. 06-4082. April 2006.

14. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-1124.

15. Kokkinos PF, Narayan P, Colleran JA, et al. Effect of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995;333:1462-1467.

16. NHLBI [National Institutes of Health, National Heart, Lung, and Blood Institute]. Your Guide to Physical Activity and Your Heart. NIH Publication No. 06-5714. June 2006.

17. NHLBI [National Institutes of Health, National Heart, Lung, and Blood Institute]. Diseases and conditions index. Available at: http://www.nhlbi.nih.gov/health/dci/Diseases/Cad/CAD_WhatIs.html. Accessed: January 2, 2007.

18. Surgeon General of the United States. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity, 2001. Washington, DC; 2001.

19. CDC [Centers for Disease Control and Prevention]. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Rev ed. Atlanta, Ga: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004.

20. NHLBI [National Institutes of Health, National Heart, Lung, and Blood Institute]. Your Guide to Lowering Your Cholesterol with TLC. 2005.

21. Kromhout D, Menotti A, Kesteloot H, Sans S. Prevention of coronary heart disease by diet and lifestyle: evidence from prospective cross-cultural, cohort, and intervention studies. Circulation 2002;105:893-898.

22. CDC [Centers for Disease Control and Prevention]. State-specific prevalence of obesity among adults—United States. MMWR Morbid Mortal Wkly Rep 2006;55:985-988.

23. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K, for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2005;142:525-531.

24. Schroeder SA. What to do with a patient who smokes. JAMA 2005;294:482-487.

25. Tests. Lab Tests Online^®. Available at: http://www.labtestonline.org. Accessed: January 2, 2007.

26. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang Y-F. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001;32:1104-1111.

27. Drug Facts and Comparisons, 60th Edition. St. Louis, Mo: Facts and Comparisons; 2006.

28. Perindopril erbumine (Aceon) PI. Solvay Pharmaceuticals. May 2005.

29. HOPE Study Investigators [Heart Outcomes Prevention Evaluation Study Investigators]. Effects of an angiotensin-converting–enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.

30. AHA [American Heart Association]. 2005 Heart Disease and Stroke Statistics—2005 Update. Dallas, Tex: American Heart Association; 2005.

31. King Pharmaceuticals, Inc. SMR/IMS Health NPA Legacy. November 2006.

32. Kaplan NM, on behalf of the Clinical Altace^® Real-World Efficacy (CARE) Investigators. The CARE Study: a postmarketing evaluation of ramipril in 11,100 patients. Clin Ther 1996;18:658-670.